Professor Graham Scotland
Interim Director of HERU
- About
-
- Email Address
- g.scotland@abdn.ac.uk
- Telephone Number
- +44 (0)1224 437181
- School/Department
- School of Medicine, Medical Sciences and Nutrition
Biography
Graham is a Professor and leads the Assessment of Technologies theme in HERU. He joined HERU in 2004 and held a joint appointment between HERU and the Health Services Research Unit (HSRU) from 2012 to 2022. His current research interests span both model- and trial-based economic evaluation, with particular emphasis on the use decision analytic modelling alongside randomised controlled trials to maximise their value for informing health care decision making. Graham graduated from the University of Edinburgh in 1998 with BSc (Hons) in pharmacology, and following this undertook an MSc in Health Services and Public Health Research at the University of Aberdeen. After completing his MSc he worked at the Dugald Baird Centre for Research in Women's Health, University of Aberdeen, where he undertook research into economic aspects of maternal healthcare delivery in developing countries. Since his appointment in HERU he has gained over 19 years’ experience working in the area of health technology assessment. Graham also has an in interest in how the broader measures of value can incorporated in health technology assessment, and in 2012 completed a part-time PhD on methods for incorporating broader measures of value into economic evaluation in the area of reproductive healthcare.
- Publications
-
Page 1 of 4 Results 1 to 25 of 85
CATHETER II, a randomised controlled trial comparing the clinical and cost effectiveness of various washout policies versus no washout policy in preventing catheter associated complications in adults living with long term catheters
BMJ OpenContributions to Journals: ArticlesDirect and indirect costs of paediatric asthma in the UK: a cost analysis
Archives of Disease in Childhood, vol. 109, no. 9Contributions to Journals: ArticlesIvosidenib for treating advanced cholangiocarcinoma with an IDH1 R132 mutation after 1 or more systemic treatments
National Institute for Health and Care Excellence (NICE). 20 pagesBooks and Reports: Commissioned Reports- [ONLINE] https://www.nice.org.uk/guidance/ta948
- [ONLINE] Page 214-316
- [ONLINE] https://www.nice.org.uk/guidance/ta948/evidence
Deucravacitinib for treating moderate-to-severe plaque psoriasis
Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care Excellence. 155 pagesBooks and Reports: Commissioned ReportsEconomic evaluation of Medically Assisted Reproduction: an educational overview of methods and applications for healthcare professionals
Best Practice & Research Clinical Obstetrics & Gynaecology, vol. 85 , pp. 217-228Contributions to Journals: ArticlesEarly detection of neovascular age-related macular degeneration: an economic evaluation based on data from the EDNA study
British Journal of Ophthalmology, vol. 106, no. 12, pp. 1754-1761Contributions to Journals: ArticlesRandomised controlled trial comparing the clinical and cost-effectiveness of various washout policies versus no washout policy in preventing catheter associated complications in adults living with long-term catheters: study protocol for the CATHETER II study
Trials, vol. 23, no. 1, 630Contributions to Journals: ArticlesManagement of the first stage of convulsive status epilepticus in adults: a systematic review of current randomised evidence
Journal of Neurology, vol. 269, no. 7, pp. 3420-3429Contributions to Journals: Review articlesReducing asthma attacks in children using exhaled nitric oxide (RAACENO) as a biomarker to inform treatment strategy: a multicentre, parallel, randomised, controlled, phase 3 trial
The Lancet. Respiratory medicine, vol. 10, no. 6, pp. 584-592Contributions to Journals: ArticlesTreatment guided by fractional exhaled nitric oxide in addition to standard care in 6- to 15-year-olds with asthma: the RAACENO RCT
Efficacy and Mechanism Evaluation, vol. 9, no. 4Contributions to Journals: ArticlesTransfer of thawed frozen embryo versus fresh embryo to improve the healthy baby rate in women undergoing IVF: the E-Freeze RCT
Health Technology Assessment, vol. 26, no. 25Contributions to Journals: ArticlesAxicabtagene ciloleucel for treating relapsed or refractory low-grade non-Hodgkin lymphoma
London: Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care Excellence. 106 pagesBooks and Reports: Commissioned ReportsElective freezing of embryos versus fresh embryo transfer in IVF: a multicentre randomized controlled trial in the UK (E-Freeze)
Human reproduction (Oxford, England), vol. 37, no. 3, pp. 476-487Contributions to Journals: ArticlesPre-hospital and emergency department treatment of convulsive status epilepticus in adults: an evidence synthesis
Health technology assessment (Winchester, England), vol. 26, no. 20, pp. 1-76Contributions to Journals: ArticlesBiomarkers for assessing acute kidney injury for people who are being considered for admission to critical care: a systematic review and cost-effectiveness analysis
Health Technology Assessment, vol. 26, no. 7, pp. 1-286Contributions to Journals: ArticlesNon-invasive testing for early detection of neovascular macular degeneration in unaffected second eyes of older adults: EDNA diagnostic accuracy study
Health Technology Assessment, vol. 26, no. 8Contributions to Journals: ArticlesCost-effectiveness and value of information analysis of NephroCheck and NGAL tests compared to standard care for the diagnosis of acute kidney injury
BMC Nephrology, vol. 22, 399Contributions to Journals: ArticlesDiagnostic Accuracy of Monitoring Tests of Fellow Eyes in Patients with Unilateral Neovascular Age-Related Macular Degeneration: Early Detection of Neovascular Age-Related Macular Degeneration Study
Ophthalmology, vol. 128, no. 12, pp. 1736-1747Contributions to Journals: ArticlesTeduglutide for treating short bowel syndrome
Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care Excellence. 123 pagesBooks and Reports: Commissioned ReportsAssessing couples' preferences for fresh or frozen embryo transfer: a discrete choice experiment
Human reproduction (Oxford, England), vol. 36, no. 11, pp. 2891-2903Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1093/humrep/deab207
- [ONLINE] View publication in Scopus
Palforzia for treating peanut allergy
London: Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care Excellence. 125 pagesBooks and Reports: Commissioned ReportsVenetoclax with a hypomethylating agent or low dose cytarabine for untreated acute myeloid leukaemia unsuitable for intensive chemotherapy
London: National Institute for Health and Care Excellence (NICE)Books and Reports: Commissioned ReportsBerotralstat for preventing acute attacks of hereditary angioedema
London: National Institute for Health and Care Excellence (NICE)Books and Reports: Commissioned ReportsCost-effectiveness and value of information analysis of multiple frequency bioimpedance devices for fluid management in people with chronic kidney disease having dialysis
Cost Effectiveness and Resource Allocation, vol. 19, 24Contributions to Journals: ArticlesThe Help for Hay Fever community pharmacy-based pilot randomised controlled trial for intermittent allergic rhinitis
npj Primary Care Respiratory Medicine, vol. 30, pp. 23Contributions to Journals: Articles